Merck (MRK) Free Cash Flow (2009 - 2026)

Merck (MRK) has reported Free Cash Flow for 18 consecutive years, with $4.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 77.03% year-over-year to $4.5 billion in Q2 2026; TTM through Jun 2026 was $16.1 billion, a 9.11% increase from a year earlier, with the FY2025 full-year figure at $12.4 billion, down 31.7% from the prior year.
• Free Cash Flow was $4.5 billion for Q2 2026 at Merck, up from $2.9 billion in the prior quarter.
• Over five years, Free Cash Flow peaked at $8.5 billion in Q3 2024 and troughed at -$743.0 million in Q4 2023.
• A 5-year average of $3.4 billion and a median of $3.1 billion in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 2290.51% in 2022 and tumbled 122.65% in 2023, its largest moves.
• Over 5 years, Free Cash Flow stood at $3.3 billion in 2022, then plunged by 122.65% to -$743.0 million in 2023, then soared by 438.22% to $2.5 billion in 2024, then declined by 27.42% to $1.8 billion in 2025, then surged by 145.45% to $4.5 billion in 2026.
• The last three Free Cash Flow figures came in at $4.5 billion (Q2 2026), $2.9 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.